Literature DB >> 30287222

Interplay between α-synuclein amyloid formation and membrane structure.

Emma I O'Leary1, Jennifer C Lee2.   

Abstract

Amyloid formation is a pathological hallmark of many pan class="Disease">neurodegenerative diseases, including lass="Chemical">pan class="Disease">Alzheimer's, Parkinson's, and Huntington's. While it is unknown how these disorders are initiated, in vitro and cellular experiments confirm the importance of membranes. Ubiquitous in vivo, membranes induce conformational changes in amyloidogenic proteins and in some cases, facilitate aggregation. Reciprocally, perturbations in the bilayer structure can be induced by amyloid formation. Here, we review studies in the last 10 years describing α-synuclein (α-syn) and its interactions with membranes, detailing the roles of anionic and zwitterionic lipids in aggregation, and their contribution to Parkinson's disease. We summarize the impact of α-syn - comparing monomeric, oligomeric, and fibrillar forms - on membrane structure, and the effect of membrane remodeling on amyloid formation. Finally, perspective on future studies investigating the interplay between α-syn aggregation and membranes is discussed. This article is part of a Special Issue entitled: Amyloids. Published by Elsevier B.V.

Entities:  

Keywords:  Aggregation; Membrane remodeling; Parkinson's disease; Protein-lipid interaction; Thioflavin T; Tubulation

Mesh:

Substances:

Year:  2018        PMID: 30287222      PMCID: PMC6445794          DOI: 10.1016/j.bbapap.2018.09.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta Proteins Proteom        ISSN: 1570-9639            Impact factor:   3.036


  124 in total

1.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

2.  Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Biochemistry       Date:  2000-03-14       Impact factor: 3.162

3.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 4.  The two-fold aspect of the interplay of amyloidogenic proteins with lipid membranes.

Authors:  Annalisa Relini; Ornella Cavalleri; Ranieri Rolandi; Alessandra Gliozzi
Journal:  Chem Phys Lipids       Date:  2008-11-14       Impact factor: 3.329

5.  Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.

Authors:  Emma I O'Leary; Zhiping Jiang; Marie-Paule Strub; Jennifer C Lee
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

6.  Cholesterol facilitates interactions between α-synuclein oligomers and charge-neutral membranes.

Authors:  Andreas van Maarschalkerweerd; Valeria Vetri; Bente Vestergaard
Journal:  FEBS Lett       Date:  2015-08-20       Impact factor: 4.124

7.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

Review 8.  Lysosomal degradation of membrane lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  FEBS Lett       Date:  2009-10-16       Impact factor: 4.124

9.  Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain.

Authors:  Latha Devi; Vijayendran Raghavendran; Badanavalu M Prabhu; Narayan G Avadhani; Hindupur K Anandatheerthavarada
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

10.  Cryo-EM structure of alpha-synuclein fibrils.

Authors:  Ricardo Guerrero-Ferreira; Nicholas Mi Taylor; Daniel Mona; Philippe Ringler; Matthias E Lauer; Roland Riek; Markus Britschgi; Henning Stahlberg
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.140

View more
  11 in total

1.  Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease.

Authors:  Briana R De Miranda; J Timothy Greenamyre
Journal:  Environ Sci Process Impacts       Date:  2020-01-30       Impact factor: 4.238

2.  Predictive Modeling of Neurotoxic α-Synuclein Polymorphs.

Authors:  Liang Xu; Shayon Bhattacharya; Damien Thompson
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

4.  Dual Effects of Presynaptic Membrane Mimetics on α-Synuclein Amyloid Aggregation.

Authors:  Yuxi Lin; Dai Ito; Je Min Yoo; Mi Hee Lim; Wookyung Yu; Yasushi Kawata; Young-Ho Lee
Journal:  Front Cell Dev Biol       Date:  2022-06-07

5.  Nanoscale Structural Analysis of a Lipid-Driven Aggregation of Insulin.

Authors:  Stanislav Rizevsky; Mikhail Matveyenka; Dmitry Kurouski
Journal:  J Phys Chem Lett       Date:  2022-03-10       Impact factor: 6.888

6.  Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.

Authors:  Upneet Kaur; Jennifer C Lee
Journal:  Acc Chem Res       Date:  2021-01-08       Impact factor: 22.384

Review 7.  α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques.

Authors:  Nicolò Bisi; Lucia Feni; Kaliroi Peqini; Helena Pérez-Peña; Sandrine Ongeri; Stefano Pieraccini; Sara Pellegrino
Journal:  Front Chem       Date:  2021-07-07       Impact factor: 5.221

Review 8.  Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let's talk about the lipids in the room.

Authors:  Bryan A Killinger; Ronald Melki; Patrik Brundin; Jeffrey H Kordower
Journal:  NPJ Parkinsons Dis       Date:  2019-11-12

9.  Unroofing site-specific α-synuclein-lipid interactions at the plasma membrane.

Authors:  Upneet Kaur; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

10.  Neutral lipids as early biomarkers of cellular fate: the case of α-synuclein overexpression.

Authors:  Natalia P Alza; Melisa A Conde; Paola G Scodelaro-Bilbao; Gabriela A Salvador
Journal:  Cell Death Dis       Date:  2021-01-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.